X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
Investing in India? Get Equitymaster Research  
FMCG stocks lose sheen 
(Fri, 26 Dec 01:30 pm) 
 
Indian share markets widened losses in the post-noon trading session. Barring IT, all the stocks are trading in the red. FMCG & auto stocks are the biggest losers today.

BSE-Sensex is down 102 points and NSE-Nifty is trading 10 points down. BSE Mid Cap is trading 0.1% up and BSE Small Cap index is trading down marginally. The rupee is trading at 63.61 to the US dollar.

Energy stocks are trading mixed with Hindustan Petroleum Corporation Ltd (HPCL) and GAIL being the biggest losers whereas Gujarat Gas and Indraprastha Gas are the major gainers. As per a leading financial daily, Reliance Industries Ltd (RIL) and its partners BP and Hardy Oil have relinquished the discovered gas block KG-D3 in the Krishna Godavari basin on account of operational restrictions by the defence ministry. The consortium led by RIL is likely to write-down Rs 14 bn invested so far in the block. RIL stock is currently trading down 0.4%.

Majority of the domestic pharma stocks are trading in the red with Panacea Biotech and Dishman Pharma being the biggest losers whereas Strides Acrolab and Torrent Pharma are among the few trading positive. As per a leading financial daily, the department of pharmaceuticals has presented a proposal to increase focus in new geographical markets such as Russia, Kazakhstan, Mexico, Brazil, Venezuala and Japan. The proposal also includes a clutch of non-traditional markets such as South Africa, Nigeria, Kenya, Saudi Arabia and the UAE. Even the European countries such as Spain, Greece, France and Italy are on the focus list to reduce dependence on the US markets. The market diversification plan comes at a time when the country's drug exports are increasingly facing regulatory backlash and pricing pressures in its biggest market US that accounts for 25% of the overall drug exports. India's pharmaceutical exports grew by a mere 1.2% to $14.8 bn in FY14.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives  RSS
Read the latest Market Commentary
 
BSE-30
 

 
Go
 

Equitymaster requests your view! Post a comment on "FMCG stocks lose sheen". Click here!

  
 

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Jul 21, 2017 (Close)

S&P BSE HEALTHCARE 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS